Mathew Forbes Romer Foundation Message for Carl Meyers

With great sadness, we mourn the passing of our loved one, Carl Meyers, who was also The Mathew Forbes Romer Foundation’s founding Vice President of Growth and Development and a member of our Board of Directors. Carl passed away peacefully on Saturday, February 8,...

Axovant Orphan Drug Designation

AXOVANT GENE THERAPIES RECEIVES ORPHAN DRUG DESIGNATION FROM FDA FOR AXO-AAV-GM1 FOR THE TREATMENT OF GM1 GANGLIOSIDOSIS NEW YORK and BASEL, Switzerland, Nov. 18, 2019 (GLOBE NEWSWIRE) — Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company...